Back to companies
Taysha Gene Therapies, Inc.
TSHAUSNASDAQPharmaceuticals & HealthcareTaysha Gene Therapies, Inc.
Revenue
$9.8mn
YoY +17.3%
Operating income
-$110.5mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API